Eribulin Equal to Older Drug in Advanced Breast Cancer
Filed under: San Antonio Drug Rehab Centers
SAN ANTONIO, Texas — In patients with heavily pretreated locally advanced or metastatic breast cancer, survival outcomes with eribulin mesylate ( Halaven, Eisai) are similar to those with capecitabine ( Xeloda, Roche), according to a study presented …
Read more on Medscape